How to Buy Celldex Therapeutics Stock
Celldex Therapeutics Inc
Celldex Therapeutics, Inc. , a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases.
Celldex Therapeutics stock last closed at $39.35, up 5.16% from the previous day, and has increased 25.52% in one year. It has overperformed other stocks in the Biotechnology industry by 0.47 percentage points. Celldex Therapeutics stock is currently +77.97% from its 52-week low of $22.11, and -26.01% from its 52-week high of $53.18.
There are currently 55.9M shares of CLDX outstanding. The market capitalization of CLDX is $2.20B. In the last 24 hours, 890,613 CLDX shares were traded.
How to Buy Celldex Therapeutics Stock
Wondering how to invest in Celldex Therapeutics stock? Here's how.
- Figure out where to buy Celldex Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you determine where to buy Celldex Therapeutics stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your payment method and add your details.
- Evaluate Celldex Therapeutics stock: The Celldex Therapeutics ticker symbol is CLDX. Is Celldex Therapeutics stock a good investment? Should you buy shares of CLDX? How do CLDX's underlying business fundamentals look? Do top analysts think Celldex Therapeutics is a good buy? Why has CLDX's stock price moved recently? (Hint: Our stock market research tools can help you figure out if CLDX is a good stock to buy).
- Make your CLDX buy order: Decide if you will purchase CLDX shares at the current market price or use a limit order to buy CLDX shares at a specific price.
- Keep an eye on your investment in CLDX: Create a watchlist to keep track of your new investment in Celldex Therapeutics shares.
Step 1: Figure out where to buy Celldex Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy CLDX shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal information so you can invest in CLDX stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new brokerage account.
- Send your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on one of the most highly reviewed stock market apps, you need to deposit funds:
Watch the tutorial below for more details depositing money into your new investment account.
Step 4: Evaluate Celldex Therapeutics stock
After you have decided on the best place to buy Celldex Therapeutics stock, it's very important to evaluate their stock before you buy, so you actually understand the risk as well as the opportunity.
Celldex Therapeutics stock data
CLDX Fundamentals
WallStreetZen was built to help average investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on CLDX's stock page.
Is CLDX stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge CLDX's intrinsic value.
Using relative valuations ratios:
- CLDX could be undervalued based on its P/B ratio of 5.13x, relative to Biotechnology industry P/B ratio of 6.02x
You can access additional valuation research on CLDX's stock here.
CLDX Financials at a glance
Passed Financial Due Diligence Checks:
- Total CLDX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the CLDX balance sheet.
- There are more short-term assets than long-term liabilities on the CLDX balance sheet.
- CLDX has $423.60M in cash and short term investments. This is sufficient to cover its annual cash burn of $109.11M.
- CLDX has cash burn of 109109000. It has enough cash and short-term investments to cover this for at least one year.
- CLDX has a low debt to equity ratio of 0.09.
Failed Financial Due Diligence Checks:
- CLDX profit margin has gone up by 27.11 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy CLDX stock, according to analysts?
Out of 4 sell side analysts who monitor CLDX, the consensus analyst rating on Celldex Therapeutics is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Celldex Therapeutics stock forecast page.
CLDX Momentum
CLDX Revenue
Last year, CLDX revenue was $6.88M. Over the past five year, CLDX's revenue has increased by -6.32% per year. This was slower than the Biotechnology industry average of 28.49%.
You can analyze CLDX's earnings and revenue performance here.
Latest Insiders Trades at CLDX
In the last year, insiders at CLDX have bought more shares than they have sold.
Freddy A. Jimenez, SVP GENERAL COUNSEL of CLDX, was the latest CLDX insider to buy. They bought $55,600.00 worth of CLDX shares on Feb 13, 2024.
Research more about who owns CLDX shares here.
Can I get consistent income from CLDX stock?
No, Celldex Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your CLDX buy order
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific price limit, use a limit order.
Click the Open button and your broker will place your order.
If you need more assistance investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your investment in CLDX
Now that you own some CLDX shares, you'll want to keep up with your new stock purchase.
Put CLDX on a watchlist to track the most important metrics related to your CLDX stock.
CLDX Feed
How to Buy Stock in Celldex Therapeutics
To reiterate, here are the 6 steps to buy stock in Celldex Therapeutics:
- Figure out where to buy Celldex Therapeutics stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Evaluate Celldex Therapeutics stock
- Make your CLDX buy order
- Keep an eye on your investment in CLDX
If you require a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to monitor your investment in Celldex Therapeutics, click the button below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.